Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
Open Access
- 14 July 2020
- journal article
- research article
- Published by Elsevier BV in Cell Reports
- Vol. 32 (3), 107940
- https://doi.org/10.1016/j.celrep.2020.107940
Abstract
No abstract availableKeywords
Funding Information
- Cystic Fibrosis Foundation
- National Institutes of Health
This publication has 59 references indexed in Scilit:
- Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirusProceedings of the National Academy of Sciences of the United States of America, 2013
- The role of transporters in the toxicity of nucleoside and nucleotide analogsExpert Opinion on Drug Metabolism & Toxicology, 2012
- Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosidesBioorganic & Medicinal Chemistry Letters, 2012
- Structural basis for active site closure by the poliovirus RNA-dependent RNA polymeraseProceedings of the National Academy of Sciences of the United States of America, 2010
- Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus InfectionPLOS ONE, 2010
- Severe Acute Respiratory Syndrome Coronavirus Infection of Human Ciliated Airway Epithelia: Role of Ciliated Cells in Viral Spread in the Conducting Airways of the LungsJournal of Virology, 2005
- Well-Differentiated Human Airway Epithelial Cell CulturesPublished by Springer Science and Business Media LLC ,2004
- Severe acute respiratory syndromeNature Medicine, 2004
- Viral Loads in Clinical Specimens and SARS ManifestationsEmerging Infectious Diseases, 2004
- SARS: epidemiologyRespirology, 2003